Characterization of the Three New Kayviruses and Their Lytic Activity Against Multidrug-Resistant Staphylococcus aureus

被引:35
|
作者
Lubowska, Natalia [1 ]
Grygorcewicz, Bartlomiej [2 ]
Kosznik-Kwasnicka, Katarzyna [3 ]
Zauszkiewicz-Pawlak, Agata [4 ]
Wegrzyn, Alicja [3 ]
Dolegowska, Barbara [2 ]
Piechowicz, Lidia [1 ]
机构
[1] Med Univ Gdansk, Fac Med, Dept Med Microbiol, PL-80204 Gdansk, Poland
[2] Pomeranian Med Univ, Dept Lab Med, Chair Microbiol Immunol & Lab Med, PL-70111 Szczecin, Poland
[3] Polish Acad Sci, Inst Biochem & Biophys, Lab Mol Biol, PL-80819 Gdansk, Poland
[4] Med Univ Gdansk, Fac Med, Dept Histol, PL-80211 Gdansk, Poland
关键词
bacteriophage; Staphylococcus aureus; Kayvirus; ANTIBIOTIC-RESISTANCE; GENOMIC ANALYSIS; BACTERIOPHAGE-K; PHAGE; MASTITIS;
D O I
10.3390/microorganisms7100471
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The development of antimicrobial resistance has become a global concern. One approach to overcome the problem of drug resistance is the application of bacteriophages. This study aimed at characterizing three phages isolated from sewage, which show lytic activity against clinical isolates of multidrug-resistant Staphylococcus aureus. Morphology, genetics and biological properties, including host range, adsorption rate, latent time, phage burst size and lysis profiles, were studied in all three phages. As analyzed by transmission electron microscopy (TEM), phages vB_SauM-A, vB_SauM-C, vB_SauM-D have a myovirion morphology. One of the tested phages, vB_SauM-A, has relatively rapid adsorption (86% in 17.5 min), short latent period (25 min) and extremely large burst size (similar to 500 plaque-forming units (PFU) per infected cell). The genomic analysis revealed that vB_SauM-A, vB_SauM-C, vB_SauM-D possess large genomes (vB_SauM-A 139,031 bp, vB_SauM-C 140,086 bp, vB_SauM-D 139,088 bp) with low G+C content (similar to 30.4%) and are very closely related to the phage K (95-97% similarity). The isolated bacteriophages demonstrate broad host range against MDR S. aureus strains, high lytic activity corresponding to strictly virulent life cycle, suggesting their potential to treat S. aureus infections.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of Methicillin-Resistant Staphylococcus aureus
    Caceres-Guido, Paulo
    Martin-Vazquez, Nicolas
    Ojeda-Sana, Adriana
    van Baren, Catalina
    Balbarrey, Ziomara
    Moreno, Silvia
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2024, 43 (02) : 73 - 78
  • [42] Thymoquinone' potent impairment of multidrug-resistant Staphylococcus aureus NorA efflux pump activity
    Ahmad, Adel Attia M.
    Abdelgalil, Sara Y.
    Khamis, Tarek
    Abdelwahab, Ashraf M. O.
    Atwa, Dina Nader
    Elmowalid, Gamal A.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] Biogenic silver nanoparticles: in vitro activity against Staphylococcus aureus methicillin-resistant (MRSA) and multidrug-resistant coagulase-negative Staphylococcus (CoNS)
    Kamila Furtado da Cunha
    Marcelle Oliveira Garcia
    Suzane Olachea Allend
    Déborah Farias Trota de Albernaz
    Luciano Aparecido Panagio
    Amilton Clair Pinto Seixas Neto
    Thaís Larré Oliveira
    Daiane Drawanz Hartwig
    Brazilian Journal of Microbiology, 2023, 54 : 2641 - 2650
  • [44] Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus
    Lin, Ming-Ching
    Hui, Cho-Fat
    Chen, Jyh-Yih
    Wu, Jen-Leih
    PEPTIDES, 2013, 44 : 139 - 148
  • [45] Multidrug-Resistant Staphylococcus aureus, India, 2013-2015
    Kumar, Mohit
    EMERGING INFECTIOUS DISEASES, 2016, 22 (09) : 1666 - 1667
  • [46] Prevalence of multidrug-resistant Staphylococcus aureus in diabetics clinical samples
    Raju, S.
    Oli, Ajay Kumar
    Patil, S. A.
    Chandrakanth, R. Kelmani
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2010, 26 (01): : 171 - 176
  • [47] Biogenic silver nanoparticles: in vitro activity against Staphylococcus aureus methicillin-resistant (MRSA) and multidrug-resistant coagulase-negative Staphylococcus (CoNS)
    da Cunha, Kamila Furtado
    Garcia, Marcelle Oliveira
    Allend, Suzane Olachea
    de Albernaz, Deborah Farias Trota
    Panagio, Luciano Aparecido
    Neto, Amilton Clair Pinto Seixas
    Oliveira, Thais Larre
    Hartwig, Daiane Drawanz
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2023, 54 (04) : 2641 - 2650
  • [48] Prevalence of multidrug-resistant Staphylococcus aureus in diabetics clinical samples
    S. Raju
    Ajay Kumar Oli
    S. A. Patil
    R. Kelmani Chandrakanth
    World Journal of Microbiology and Biotechnology, 2010, 26 : 171 - 176
  • [49] An amphipathic peptide combats multidrug-resistant Staphylococcus aureus and biofilms
    Zhang, Kun
    Yang, Na
    Mao, Ruoyu
    Hao, Ya
    Teng, Da
    Wang, Jianhua
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [50] Unprocessed milk as a source of multidrug-resistant Staphylococcus aureus strains
    Kis, Marta
    Kolacko, Ivana
    Zdolec, Nevijo
    ACTA VETERINARIA BRNO, 2021, 90 (03) : 357 - 363